'Fingerprinting' breakthrough offers improved brain tumour diagnosis

September 21, 2012

(Medical Xpress)—UK scientists have made a breakthrough in a new method of brain tumour diagnosis, offering hope to tens of thousands of people.

Researchers, led by Professor Francis Martin of Lancaster Environment Centre at Lancaster University, have shown that infrared and – coupled with – can be used to tell the difference between normal and the different tumour types that may arise in this tissue, based on its individual biochemical-cell 'fingerprint'.

Spectroscopy is a technique that allows us to analyse light interactions with samples such as tissue by generating a spectrum, which is a reflection of the interrogated sample.

Currently, when surgeons are operating to remove a it can be difficult to spot where the tumour ends and normal tissue begins.

But new research published online in this month has shown it is possible to spot the difference between diseased and normal tissue using Raman spectroscopy – a type of spectroscopy which works effectively on living tissue, giving accurate results in seconds.

This is a key development which means it is now theoretically possible to test living tissue during surgery, helping doctors to remove the complete tumour whilst preserving intact adjacent healthy tissue.

The fingerprinting technique was also able to identify whether the tumours arose in the brain or whether they were secondary cancers arising from an unknown primary site. This is a key development which could help reveal previously undetected cancer elsewhere in the body, improving .

Professor Francis Martin said: "These are really exciting developments which could lead to significant improvements for individual patients diagnosed with brain tumours. We and other research teams are now working towards a sensor which can be used during to give surgeons precise information about the tumour and tissue type that they are operating on."

The information obtained by this method can be combined with conventional methods, for example immunohistochemistry, to diagnose and grade brain tumours to allow for more accurate planning and execution of surgery and/or radiation therapy.
This offers more potential for individualised treatment and better long-term survival.

Explore further: Researchers uncover new operations of cancer suppressor

More information: K Gajjar et al, Anal. Methods, 2012, DOI: 10.1039/c2ay25544h . http://pubs.rsc.org/en/content/articlelanding/2012/ay/c2ay25544h

Related Stories

Research makes significant cancer breakthrough

August 8, 2012

(Medical Xpress) -- A major breakthrough by scientists at Queen's University Belfast could lead to more effective treatments for throat and cervical cancer. The discovery could see the development of new therapies, which ...

Improved image analysis for MRI

July 16, 2012

Reliable, accurate and repeatable analysis of medical images continues to be a challenge in disease treatment. A European research initiative has developed robust and efficient computing techniques for image data interpretation, ...

Treatment of common virus can reduce tumour growth

September 27, 2011

Researchers at Karolinska Institutet in Sweden have demonstrated for the first time that it is possible to inhibit the growth of brain tumours by treating the common Cytomegalovirus (CMV). The virus, which is found in a wide ...

Recommended for you

Artificial beta cells

December 8, 2016

Researchers led by ETH Professor Martin Fussenegger at the Department of Biosystems Science and Engineering (D-BSSE) in Basel have produced artificial beta cells using a straightforward engineering approach.

Key regulator of bone development identified

December 8, 2016

Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes—a condition known as brachydactyly. The discovery was made by researchers at Penn State ...

Researchers question lifelong immunity to toxoplasmosis

December 8, 2016

Medical students are taught that once infected with Toxoplasma gondii—the "cat parasite"—then you're protected from reinfection for the rest of your life. This dogma should be questioned, argue researchers in an Opinion ...

TET proteins drive early neurogenesis

December 7, 2016

The fate of stem cells is determined by series of choices that sequentially narrow their available options until stem cells' offspring have found their station and purpose in the body. Their decisions are guided in part by ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.